Trial Profile
Insulin-aspart/insulin-protamine-aspart vs insulin detemir in patients with type 2 diabetes mellitus inadequately controlled with oral antihyperglycaemics alone
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Oct 2013
Price :
$35
*
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Insulin detemir (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ONCE-J
- 23 Oct 2012 New trial record
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.